Corimmun

About:

Corimmun is a drug development company focused on therapeutics and diagnostics for heart and vascular diseases.

Top Investors: Bayern Kapital, MIG Capital, HTGF | High-Tech Gruenderfonds

Description:

Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.

Total Funding Amount:

13.1M EUR

Headquarters Location:

Martinsried, Bayern, Germany

Founded Date:

2006-01-01

Contact Email:

info(AT)corimmun.com

Founders:

Number of Employees:

Last Funding Date:

2010-10-31

IPO Status:

Private

Industries: